Trial
NCT02054936
Evaluation of Wound Drainage After Knee or Hip Arthroplasty
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Michigan
Collaborators
—
Condition
Complications
Intervention
Rivaroxaban (Xarelto)
Why stopped
Change in standard of care, no possibility of recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-07